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I. INTRODUCTION 
Which will you choose for the future of medicine: Machine or 
human?  For certain diseases, a fully automated surgery, performed 
using artificial intelligence (“AI”) technology has a mortality rate of 1% 
                                                          
 *   Currently, Dr. Matsuzaki, an orthopedic surgeon by trade, works at the 
University of Tokyo as an Innovation Fellow for Japan Biodesign.  Previously, he 
served as a visiting scholar at UC San Diego and as a postdoctoral fellow at Scripps 
Research.  He is presently working on robotics for orthopedics, artificial muscle, 
machine learning, and anti-aging genes for the joint cartilage. 
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due to mechanical error, while the same surgery performed by a human 
surgeon has a mortality rate of 10% due to human error.1  In the wake 
of the recent technological advancements in medicine, the ethical 
implications of AI must be closely examined, especially since parts of 
the surgical process will soon be replaced by automation. 
Recently, the development of “deep learning” or “deep structured 
learning” methods, in contrast to task-specific learning algorithms, has 
created an explosion in the rapid advancement of AI. In recent medical 
journals, many studies report high accuracy of imaging diagnosis using 
AI.  Specifically, in some instances, AI devices have already exceeded 
the mean diagnostic rate of doctors, making AI technology an attractive 
and accurate diagnostic instrument.2 
Robot automation has also been studied using machine learning 
algorithms.3  Fully autonomous surgical robots will soon emerge given 
the inherent visual advantages provided by robots and the continued 
development of machine learning algorithms.  Consequently, AI will 
become a crucial tool for assisting doctors and improving accuracy. 
                                                          
1.  See Interpretable Machine Learning, 2v2 Debate: Caruana, Simard vs. 
Weinberger, LeCun. Interpretable ML Symposium, NIPS 2017, YOUTUBE (Dec. 12, 
2017), https://www.youtube.com/watch?v=2hW05ZfsUUo (noting the 10% mortality 
rate for surgeries performed by humans and highlighting that AI technology may be a 
safer way to perform surgery compared to the traditional human only method); see 
also Thierry Langanay et al., Aortic Valve Replacement in the Elderly: The Real Life, 
93 ANNALS OF THORACIC SURGERY 70, 70–72 (2012) (observing that the mortality 
rate of patients ages 80–96 during aortic valve replacement was 6.9% when performed 
by a human surgeon).  
2.  See generally Andre Esteva et al., Dermatologist-level Classification of Skin 
Cancer with Deep Neural Networks, 542 NATURE 115, 117–18 (2017) (finding that 
AI technology exceeded the mean diagnostic rate of most human dermatologists when 
classifying and identifying skin cancer); see also Varun Gulshan et al., Development 
and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy 
in Retinal Fundus Photographs, 316 JAMA 2402, 2403, 2407–08 (2016) (noting that 
automated and semi-automated evaluations of diabetic retinopathy “had high 
sensitivity and specificity for detecting diabetic retinopathy and macular edema” in 
pictures). 
3.  See generally Yohannes Kassahun et al., Surgical Robotics Beyond 
Enhanced Dexterity Instrumentation: A Survey of Machine Learning Techniques and 
Their Role in Intelligent and Autonomous Surgical Actions, 11 INT’L J. OF COMPUTER 
ASSISTED RADIOLOGY & SURGERY 553, 553 (2016) (detailing AI technology and 
machine learning used in surgery). 
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AI is becoming more essential to the medical field due to the 
expansion in the amount of patient medical data collected, including 
patients’ physiologic sensor data from wearable devices, genetic 
sequences, and race-dependent treatment options.  As a physician, it is 
impossible to review all the data.  Therefore, it is becoming clear that 
AI is necessary to analyze and prioritize what has become known as 
“big data,” which is defined as “information assets 
characterized by such a high volume, velocity, and variety to 
require specific technology and analytical methods for its 
transformation into value.”4  Additionally, a recent study indicated that 
in 21% of primary care patient cases the final diagnosis was completely 
different from the referral diagnosis, demonstrating the critical need for 
standardized diagnostic methods.5 
Furthermore, the staggering number of deaths related to medical 
errors is another reason AI is a much-needed asset in the medical field.  
In the United States, medical error related deaths range from 210,000 
to 400,000 annually.6  These deaths are primarily caused by missed 
diagnoses and the lack of appropriate treatment.7  The accuracy of AI 
technology can help reduce the number of deaths due to medical error.  
Surgical errors are also a big problem.  According to a Mayo Clinic 
study published in 2017, 8.9% of surgeons reported making a medical 
error in the preceding three months.8  This concerning statistic urges for 
a more stable and secure medical treatment system, which can be 
accomplished through supervised autonomous surgery or fully 
autonomous surgery. 
                                                          
4.  Andrea De Mauro et al., What is Big Data? A Consensual Definition and a 
Review of Key Research Topics, 4TH INTERNATIONAL CONFERENCE ON INTEGRATED 
INFORMATION 8 (Sep. 2014), https://www.researchgate.net/publication/265775800_ 
What_is_Big_Data_A_Consensual_Definition_and_a_Review_of_Key_Research_T
opics. 
5.  See Monica Van Such et al., Extent of Diagnostic Agreement Among Medical 
Referrals, J. OF EVALUATION IN CLINICAL PRACTICE, Feb. 2017, at 2.  
6.  See John T. James, A new, Evidence-based Estimate of Patient Harms 
Associated with Hospital Care, 9 J. OF PATIENT SAFETY 122, 122, 126 (2013) (finding 
that by “[u]sing a weighted average of the 4 studies, a lower limit of 210,000 deaths 
per year was associated with preventable harm in hospitals.”). 
7.  See id. at 123, 126.  
8.  Tait Shanafelt et al., Preventable Deaths in American Hospitals, NEJM 
CATALYST (Jan. 23, 2017), https://catalyst.nejm.org/medical-errors-preventable-
deaths/. 
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This article describes the details of recent approaches to the 
application of AI in medicine, the limitations and potential problems of 
AI, as well as the accompanying ethical issues involved in 
implementing this new technology.  Part II of this article provides the 
history of AI and the current function of AI in medicine.  Part III 
discusses the third boom, deep learning, as well as another algorithm 
type, and describes medical applications using the latest algorithms.  
Finally, Part IV examines the problems related to AI and the ethical 
implications that should be considered when applying AI to medical 
care. 
II. THE HISTORY OF ARTIFICIAL INTELLIGENCE 
AI has a robust history spanning over seventy years.  The mid 1950s 
is considered the first boom of AI and is often referred to as the era of 
exploring and reasoning.  During the first boom, the concept of the 
perceptron was born, which gives one output from multiple inputs–the 
basis of deep learning.9  In 1955, mathematics professor John McCarthy 
coined the term “AI” in his grant application seeking funds for the 1956 
Dartmouth AI Conference.10  In the same period, Alan Turing proposed 
the “Turing test” to evaluate a machine’s capability by analyzing 
whether the intelligent behavior of a machine is equivalent to that of a 
human.11  Then, in the early 1970s, AI systems were developed as 
diagnostic and therapeutic tools for the medical field. 
The second boom, called the knowledge-based era, occurred 
around 1980, with the development of a system emulating the 
                                                          
9.  See generally F. Rosenblatt, The Perceptron: A Probabilistic Model for 
Information Storage and Organization in the Brain, 65 PSYCHOL. REV. 386, 387, 399–
401 (1958) (finding that a “theory has been developed for a hypothetical nervous 
system, or machine, called a perceptron” which is “designed to illustrate some of the 
fundamental properties of intelligent systems.”). 
10.  See generally J. McCarthy et al., A Proposal for the Dartmouth Summer 
Research Project on Artificial Intelligence, (Aug. 31, 1955), http://www.formal. 
stanford.edu/jmc/history/dartmouth/dartmouth.html (detailing the proposed two-
month long study of “artificial intelligence,” a newly coined term at the time, in order 
to obtain a deeper understanding of machine learning).  
11.  See A.M. Turing, Computing Machinery and Intelligence, 49 MIND 433, 
433, 441 (1950) (explaining the evaluation methods required to determine whether 
machines can “think” and suggesting “at the end of the century . . . one will be able to 
speak of machines thinking without expecting to be contradicted.”).  
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knowledge of a human expert, called an expert system.12  During this 
time, Stanford University developed a system that used AI technology 
to diagnose infectious blood diseases, called “MYCIN,”13 while the 
University of Pittsburgh developed a computer-assisted diagnostic tool 
known as “INTERNIST-I.”14  However, complicated processes, such 
as the presence of comorbidity and clinical course, make it difficult for 
these systems to provide an accurate diagnosis and make treatment 
recommendations.15 
Also, during the second boom, automatic diagnostic equipment, 
used to evaluate electrocardiograms, was developed.16  Although 
diagnostic equipment serves as an effective screening test, the 
diagnostic rate of myocardial infarction, in which a specific signal rises, 
is poor.17  On the other hand, more successful developments emerged 
in the second boom, such as algorithms like the multi-layered 
perceptron,18 which is a basic architecture of deep learning.  Also, 
backpropagation was developed, which allows for tuning the 
parameters.19  Additionally, the basic algorithms of current AI, such as 
                                                          
12.   See PETER JACKSON, INTRODUCTION TO EXPERT SYSTEMS 1–2 (Addison-
Wesley ed., 3d ed. 1998). 
13.  Edward H. Shortliffe & Bruce G. Buchanan, A Model of Inexact Reasoning 
in Medicine, 23 MATHEMATICAL BIOSCIENCES 351, 353–54 (1975).  
14. See Randolph A. Miller et al., Internist-1, An Experimental Computer-based 
Diagnostic Consultant for General Internal Medicine, 307 NEW ENG. J. OF MEDICINE 
468, 468 (1982). 
15.  See Gaurav Sharma & Alexis Carter, Artificial Intelligence and the 
Pathologist: Future Frenemies?, 141 ARCHIVES OF PATHOLOGY & LABORATORY 
MEDICINE 622, 622–23 (2017) (noting that some limitations of using AI technology 
for diagnostic purposes).  
16.  Mats-Erik Nygårds & Johan Hulting, An Automated System for ECG 
Monitoring, 12 COMPUTERS & BIOMEDICAL RES. 181, 181 (1978).  
17.  Myocardial infarction occurs when the heart muscle stops or decreases 
blood flow to the heart, which can result in death. See Antoine Ayer & Christian Juhl 
Terkelsen, Difficult ECGs in STEMI: Lessons Learned from Serial Sampling of Pre- 
and In-hospital ECGs, 47 J. ELECTROCARDIOLOGY 448, 448, 456 (2014), for a 
discussion of certain types of electrocardiogram signals and patterns that are typically 
incorrectly identified by AI algorithms.  
18.  See generally D. E. Rumelhart et al., A General Framework for Parallel 
Distributed Processing, in PARALLEL DISTRIBUTED PROCESSING: EXPLORATIONS IN 
THE MICROSTRUCTURE OF COGNITION, VOL. 1: FOUNDATIONS 45, 60 (MIT Press ed., 
1986). 
19.  Id. at 51.  
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recurrent neural networks, were popularized and developed during this 
period.20  Since the 2000s, the neural network architecture, along with 
improvements in computer performance, has increased to multiple 
layers, thereby endowing machine learning with higher accuracy. 
III. THE THIRD BOOM: DEEP LEARNING AND LEARNING STYLES, AND 
THE MEDICAL APPLICATION USING THE LATEST ALGORITHMS 
In 2006, the beginning of the third boom was sparked when AI 
acquired a “vision” of deep learning through the work of Geoffrey 
Hinton, of Toronto University.  Hinton proposed a new algorithm, 
called deep belief networks, and demonstrated its effectiveness on a 
deep learning algorithm.21  Hinton’s work won the ImageNet 
competition in 2012, which recognized the visual image (“ImageNet”) 
for its image recognition accuracy.22  Through the development of 
ImageNeT, a significant reduction in the error rate of image 
classification was achieved, which dramatically improved the function 
of the algorithm using deep learning.23  As a result of this tremendous 
improvement in machine learning algorithms, many researchers began 
to utilize deep learning as a major algorithm. 
Machine learning is an integral part of AI.  Machine learning is 
defined as: (1) an algorithmic computing approach to making a 
determination or prediction, (2) acting without being explicitly 
programmed, and (3) automatically improving itself.24  Machine 
learning has many kinds of algorithms.  Deep learning is one 
                                                          
20.  See J.J. Hopfield, Neural Networks and Physical Systems with Emergent 
Collective Computational Abilities, 79 PROC. OF THE NAT’L ACAD. OF SCI. OF THE 
U.S. 2554, 2555–56 (1982) (explaining how neural networks used in AI technology 
work mathematically). 
21.  Geoffrey Hinton et al., A Fast Learning Algorithm for Deep Belief Nets, 18 
NEURAL COMPUTATION 1527, 1527–28, 1530–31 (2006). 
22.  See Alex Krizhevsky, Ilya Sutskever & Geoffrey E. Hinton, ImageNet 
Classification with Deep Convolutional Neural Networks, 60 COMMUNICATIONS OF 
THE ACM 84, 84 (2017) (discussing the “deep convolutional neural network” Hinton 
and his team used to classify over 1.2 million images in the ImageNet competition).  
23.  See id. at 90–91. 
24.  Cf. Arthur L. Samuel, Some Studies in Machine Learning Using the Game 
of Checkers, 3 IBM J. OF RES. & DEV. 210, 210 (highlighting aspects of machine 
learning by studying a machine’s ability to learn and to improve playing the game of 
checkers).  
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algorithmic approach to implementing machine learning, by using 
multi-layer artificial neural networks that mimic human neural 
architecture.25  The development of high-performance computing 
systems, such as graphics processing units and field-programmable gate 
arrays, have also accelerated AI development.  Additionally, open-
source AI frameworks, which are software libraries for designing and 
deploying numerical computations, have contributed to strengthen AI 
algorithms.  Examples of these frameworks include TensorFlow or 
Caffe, and GitHub, which is a platform of open-source projects.  More 
recent achievements in AI are the use of high performance speech 
recognition and natural language processing by deep learning 
algorithms, or combinations of deep learning and other algorithms. 
A. Learning Styles 
There have been major learning styles developed for training 
machine learning algorithms and neural networks.  These 
advancements in learning styles are capable of extending the potential 
of AI in the following ways: (1) Supervised learning, where the data is 
labeled and annotated; (2) Unsupervised learning, where data is not 
labeled or annotated; (3) Transfer learning, which incorporates the use 
of pre-trained neural networks for another task; (4) Reinforcement 
learning, which gets an agent to act on a task so as to maximize its 
rewards; and (5) Meta-learning, which is trained by exposure to a large 
number of tasks and then testing the machine’s  ability to learn the new 
task, also known as “learning to learn.”26 
For example, under the theory of supervised learning, the labeled 
medical data would be pathologic diagnosis, physician’s diagnosis, or 
genomic data.  A tremendous amount of time and effort is required to 
create this labeled data.  Aside from the time commitment, this learning 
style requires the neural networks to be trained and involves a large 
number of pre-labeled images.  In contrast, in unsupervised learning, 
unlabeled data is used to train neural networks and to generate useful 
                                                          
25.  See Yann LeCun et al., Deep Learning, 521 NATURE 436, 436, 438 (2015). 
26.  See generally Chelsea Finn et al., Model-Agnostic Meta-Learning for Fast 
Adaptation of Deep Networks, 34TH INTERNATIONAL CONFERENCE ON MACHINE 
LEARNING 1–4 (Jul. 18, 2017), https://arxiv.org/abs/1703.03400 (describing an 
algorithm for meta-learning and providing an overview of common learning styles 
used for AI). 
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clusters that have specific features and can be labeled data.27  However, 
“unsupervised learning sometimes requires much larger training 
datasets” compared to supervised learning.28  Transfer learning utilizes 
the pre-trained neural networks, which are trained by unsupervised 
learning or supervised learning.29  Transfer learning usually requires 
smaller datasets than those used to initially train the model.30  While 
supervised learning, unsupervised learning, and transfer learning are 
used for image classification, reinforcement learning is used mostly for 
taking action, such as in computer games, simulation, and surgical 
procedures.  Reinforcement learning is a system that finds the most 
effective way to maximize given rewards, i.e., learning by trial and 
error.  In 2017, this type of algorithm, developed by DeepMind 
Technologies and AlphaGo, was given media attention when it was 
reported to have outperformed the previously top-ranked human 
champions.31 
Furthermore, reinforcement learning is expected to enhance 
personalized medicine by enabling physicians to optimize treatment 
strategies and treatment recommendations.32  Also, Meta-learning has 
recently been developed in a manner which produces a learning 
algorithm which can essentially “learn” the algorithm itself.33  The 
                                                          
27.  Marc Kohli et al., Implementing Machine Learning in Radiology Practice 
and Research, 208 AM. J. ROENTGENOLY 754, 756 (2017).  
28.  Id.  
29.  See id. at 758–59 (providing an overview of transfer learning). 
30.  See id.  
31.  See Darrell Etherington, Google’s AlphaGo AI Defeats Team of Five 
Leading Go Players, TECHCRUNCH (May 26, 2017), https://techcrunch.com/2017 
/05/26/googles-alphago-ai-defeats-team-of-five-leading-go-players/ (reporting that 
AI computer technology “defeated a team made up of five [human] Go champions in 
a demonstration match” playing a game called “Go”).  
32.  See Yuxi Li, Deep reinforcement learning: An overview, 34 (Sept. 15, 
2017), https://arxiv.org/pdf/1701.07274.pdf (discussing reinforcement learning in the 
context of healthcare and medicine); see also Niranjani Prasad et al., A Reinforcement 
Learning Approach to Weaning of Mechanical Ventilation in Intensive Care Units, 1 
(Apr. 20, 2017), https://arxiv.org/pdf/1704.06300.pdf (discussing the possibility of 
creating a AI technology-based “decision support tool that leverages available patient 
information in the data-rich ICU setting to alert clinicians when a patient is ready for 
initiation of weaning, and to recommend a personalized treatment protocol.”).  
33.  See Finn et al., supra note 26, at 1 (noting “the goal of meta-learning is to 
train a model on a variety of learning tasks, such that it can solve new learning tasks 
using only a small number of training samples.”). 
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Meta-learning algorithm is trained by exposure to a certain task and 
then undergoes testing in this new task.34  Meta-learning streamlines 
the learning process because it is faster and more efficient to learn a 
new task, than to learn by reinforcement.35  This algorithm can be used 
for industrial robots and, most importantly, has the potential to perform 
medical robotic tasks. 
B. AI in Medical Image Diagnosis 
In the past two years, a few highly influential papers, concerning 
AI and medical diagnostics, have been published.  The first paper was 
published by Google and describes automated diagnosis of diabetic 
retinopathy using retinal images.36  The authors of the Google article 
used a deep learning algorithm, coupled with transfer learning, to 
diagnose diabetic retinopathy.37  A few months after Google’s paper 
was published, Stanford University published a paper about skin cancer 
diagnosis using a similar method.38  Aside from these two significant 
publications, around this same time, numerous countries competed in 
the Cancer Metastases in Lymph Nodes Challenge 2016 
(“CAMELYON16”) competition, which was organized to study 
algorithms used to detect metastases in lymph nodes, and resulted in the 
publication a study.39  The CAMELYON16 study serves as a good 
example of an international initiative to improve diagnostic accuracy 
using AI technology.  Collectively, all three publications proved that 
the deep learning algorithm outperformed human doctors; in fact, AI 
was more accurate than doctors. 
In February 2018, the US Food and Drug Administration (“FDA”) 
announced marketing clearance for Viz, which is AI’s Contact 
                                                          
34.  See id. at 1, 5–6. 
35.  See id. at 1, 4–6. 
36.  See Gulshan et al., supra note 2, at 2402, for the Google sponsored study. 
37.  Id. at 1.  
38.  See Esteva et al., supra note 2, at 115, for the study conducted by Stanford 
University concerning skin cancer classifications using neural networks. 
39. See Babak Ehteshami Bejnordi et al., Diagnostic Assessment of Deep 
Learning Algorithms for Detection of Lymph Node Metastases in Women with Breast 
Cancer, 318 JAMA 2199, 2199, 2208 (2017), for the CAMELYON16 study finding 
deep learning algorithms can be helpful for pathological diagnosis notwithstanding 
certain practical limitations. 
9
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application.  Viz is the first AI-based clinical decision support system 
and can analyze computed tomography images and alert healthcare 
providers to a possible stroke in patients.40  Two months after the 
announcement of Viz, the FDA permitted the marketing of the first 
medical device using AI to detect diabetic retinopathy.41 
C. AI in Robotic Surgery 
Machine learning and deep learning are now studied for robotic 
automation, marking the first step on the path toward fully autonomous 
surgery.  In response to this progression, some commercial products are 
currently available, such as: (1) Direct control: da Vinci surgical system 
(Intuitive Surgical, USA); (2) Shared control: Mako Robotic-Arm 
Assisted Surgery (Stryker, USA); (3) Supervised autonomy: 
CyberKnife (Accuray, USA); and (4) Fully autonomous, which is not 
yet available.42 
The widely used da Vinci robotic surgical system, approved in 
2000 by the US FDA, is a direct control surgical system with a master 
console and controller on the surgeon’s side and moving robotic arms 
on the patient’s side.43  Aside from a direct control surgical system, 
there is also what is known as a shared control system.  An example of 
a shared control system is the Mako Robotic-Arm Assisted Surgery that 
is designed for knee or hip replacement.44  The shared control system 
allows the doctor to guide the robotic arm to achieve the preplanned 
removal of the bone and cartilage.  In these types of robotic surgeries, 
                                                          
40.  FDA Permits Marketing of Clinical Decision Support Software for Alerting 
Providers of a Potential Stroke in Patients, U.S. FOOD & DRUG ADMIN., 
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm596575.htm 
(last updated Feb. 13, 2018).  
41.  See FDA Permits Marketing of Artificial Intelligence-Based Device to 
Detect Certain Diabetes-Related Eye Problems, U.S. FOOD & DRUG ADMIN.,  
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604357.htm 
(last updated Apr. 12, 2018) [hereinafter FDA Diabetes Detection Device].  
42.  Micheal Yip & Nikhil Das, Robot Autonomy for Surgery, 2–4 (July 10, 
2017), https://arxiv.org/pdf/1707.03080.pdf. 
43.  See generally DA VINCI SURGERY: MINIMALLY INVASIVE SURGERY, 
http://www.davincisurgery.com/ (last visited Dec. 3, 2018). 
44.  See generally Mako Robotic-Arm Assisted Technology, STRYKER, 
https://patients.stryker.com/mako-robotic-arm-assisted-technology (last visited Dec. 
3, 2018). 
10
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the surgeon is able to get haptic feedback to prevent bone resection 
outside the preplanned area.  The shared control of the doctor and the 
robotic arm allows for a more accurate surgery compared to the 
conventional method.45 
The next level of robotic surgery is supervised autonomy.  An 
example of a supervised autonomy device is the CyberKnife.  The 
CyberKnife is a noninvasive radiotherapy device for tumor removal 
which requires the doctor to define the area of radiation, and then 
automated focused radiation is applied.46  Currently, there are no fully 
autonomous devices available in the United States.  However, in 
September 2017, a Chinese hospital reported having a fully autonomous 
dental implant surgery device.47  Although, this fully autonomous 
dental implant device is not commercially available yet. 
Further, researchers at The Sheikh Zayed Institute for Pediatric 
Surgical Innovation in Washington D.C., published a paper regarding 
the performance of automated surgery.  The paper demonstrated that a 
supervised autonomous surgical robot and an autonomous robot each 
outperformed open surgery, laparoscopic surgery, and robot-assisted 
surgery, which is similar to the da Vinci device used to suture a pig 
intestine.48  Although, it will be a while before full automation is 
available for other types of surgery.  In the meantime, some portions of 
the surgical process are likely to be replaced by automation. 
                                                          
45.  See Eli Kamara et al., Adoption of Robotic vs Fluoroscopic Guidance in 
Total Hip Arthroplasty: Is Acetabular Positioning Improved in the Learning Curve?, 
32 THE J. OF ARTHROPLASTY 125, 126–130 (2017) (concluding “a new haptic robotic 
technique for acetabular bone preparation and cup insertion” was a precise and 
accurate surgical method); see also Stuart W. Bell et al., Improved Accuracy of 
Component Positioning with Robotic-Assisted Unicompartmental Knee Arthroplasty: 
Data from a Prospective, Randomized Controlled Study, 98 THE J. OF BONE & JOINT 
SURGERY AM. 627, 627–28, 630–33 (2016) (finding that “[r]obotic-assisted surgical 
procedures . . . lead to improved accuracy of implant positioning compared with 
conventional unicompartmental knee arthroplasty surgical techniques.”). 
46.  See generally General Information, CYBERKNIFE ACCURACY, 
http://www.cyberknife.com/treatment/radiation-therapy/general (last visited Dec. 3, 
2018). 
47.  See Chinese Robot Dentist is First to Fit Implants in Patient’s Mouth 
without any Human Involvement, SOUTH CHINA MORNING POST, http://www.scmp. 
com/news/china/article/2112197/chinese-robot-dentist-first-fit-implants-patients-
mouth-without-any-human (last updated Sep. 22, 2018).  
48.  See Azad Shademan et al., Supervised Autonomous Robotic Soft Tissue 
Surgery, SCI. TRANSLATIONAL MED., May 4, 2016, at 1, 4–6. 
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IV. LIMITATIONS AND THE POTENTIAL PROBLEMS OF AI 
Over the past few years, AI has become the dominant choice for 
image diagnosis in medicine. Although still in the experimental phase, 
autonomous AI systems will be used in the future for completing 
surgery, recommending treatments, predicting medical conditions, 
analyzing health data, analyzing genomic data, and generally, as robotic 
diagnostic tools. However, before these systems become fully 
integrated in the medicine, the limitations of the algorithm, the liability 
of the diagnosis produced by AI, security, and privacy in interacting 
with patient data, and morality of medical actions should be explored. 
A. The Need for Massive Data Training and Issues with Reliability 
Massive amounts of data are needed to properly train the neural 
networks and to ensure an optimal neural network algorithm.  Without 
enough image data, robust and accurate systems cannot be developed.  
In turn, this can lead to overfitting,49 which does not generalize well to 
new data.  Also, it may be difficult to establish AI in certain countries 
because they do not have enough data needed to train the neural 
networks.  One example of this data disparity is in Chile, where the total 
number of computed tomography and magnetic resonance imaging 
examinations is approximately 4 to 10 times smaller than in the United 
States.  Additionally, deep learning relies heavily on labeled data to 
ensure the quality of the output of the algorithm.  Consequently, these 
datasets require many experts and data analysists.  Open-source data is 
available for some rare diseases.50  However, for more common 
diseases, data is not made publicly available. 
For common diseases, it should be considered whether AI 
technology will be cost-effective.  Some factors to be explored are the 
                                                          
49.  Overfitting occurs when the data is trained too well, which leads to the 
inability to fit the evaluation data and causes poor performance. See Krizhevsky, 
Sutskever & Hinton, supra note 22, at 88–89 (describing methods to reduce 
overfitting such as the “dropout” method which “consists of setting to zero the output 
of each hidden neuron with probability 0.5” resulting in “neurons which are ‘dropped 
out’” and “do not contribute to the forward pass and do not participate in 
backpropagation.”).  
50.  See Mathew I. Bellgard et al., Second Generation Registry Framework, 
SOURCE CODE FOR BIOLOGY & MED., June 20, 2014, at 4 (noting that there is a “rare 
disease registry using the second generation RDRF. . . available.”). 
12
California Western Law Review, Vol. 55 [2019], No. 1, Art. 7
https://scholarlycommons.law.cwsl.edu/cwlr/vol55/iss1/7
FINAL Matsuzaki camera ready (Do Not Delete) 1/2/2019  10:40 AM 
2018]  ETHICAL ISSUES OF ARTIFICIAL INTELLIGENCE IN MEDICINE 267 
amount of time it takes for experts to label the data and the source of 
the data.  Another consideration is the potential lack of information in 
the dataset, i.e., a missing value.  Although structured data is easier to 
input and generally more complete, most biomedical data is not 
designed for AI training datasets.  However, to combat these data set 
requirements, some scientists have shown that deep learning can be 
easily fooled by an extremely similar image that is far from the actual 
image.  For example, deep learning systems have mistaken blue and 
orange wavy lines for starfish.51  However, currently this is not a 
completely viable solution for the lack of data because the output of the 
result is not always correct.  The overall concern is the reliability of the 
data, which indicates that at this stage of development, a human doctor 
should make the final decision. 
B. Lack of Transparency and Lack of Evidence 
The “hidden layer,” is the middle layer of the neural networks in 
the deep learning algorithm and includes millions of parameters.52  
Although these parameters are optimized by automatic calculations, it 
is very difficult to determine how these parameters work and interact 
with each other.  This inability to see how the parameters work is known 
as the “black box.”  Some studies have tried to shed light on this 
phenomenon, but the issue of transparency remains unsettled.53  While 
deep learning has a “black box,” “Explainable AI” is an available 
transparent algorithm containing decision trees and random forests.  
However, the performance of the transparent algorithm in image 
recognition, is far from acceptable.54  Another area of inquiry is whether 
                                                          
51.  Anh Nguyen et al., Deep Neural Networks are Easily Fooled: High 
Confidence Predictions for Unrecognizable Images, 1, 4–5 (Apr. 2, 2015), https://arx 
iv.org/pdf/1412.1897.pdf.  
52.  See Krizhevsky, Sutskever & Hinton, supra note 22, at 84, 91, for a study 
utilizing deep conventional neural networks, which encompasses this “hidden layer” 
of neural networks. 
53.  See generally Davide Castelvecchi, The Black Box of AI, 538 NATURE 20, 
21, 23 (2016) (detailing attempts to solve the issue of transparency and how the issue 
has caused scientists to have to create AI methods that do not use deep learning). The 
explanation for transparency is very difficult to express in this paper. A more 
comprehensive example would be in the form of a mathmatical expression.  
54.  See generally David Gunning, Explainable Artificial Intelligence (XAI), 
DEFENSE ADVANCED RESEARCH PROJECTS AGENCY, https://www.darpa.mil/program/ 
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it is necessary to be able to explain how automated decisions are made, 
given that human explanations of decisions and predictions are usually 
wrong.55  A recent algorithm study found AI is useful for diagnosing 
images, predicting a medical condition, and analyzing big health data.56  
However, this finding has not been backed up by other researchers to 
confirm its validity. 
Countries should independently establish the evidence used in AI 
systems.  Studies have found that computer-aided diagnosis for imaging 
have outperformed human-only diagnosis, proving that human doctors 
combined with AI will have a better outcome than humans in medical 
image diagnosis.57  However, randomized clinical trials are required to 
confirm this hypothesis.  Additionally, other applications of AI, 
including predictive medicine, treatment recommendations, and 
analysis of big health data and genomic data, should be explored by a 
randomized control study. 
C. Liability, Security, and Privacy 
Who is going to take responsibility for the AI system? This debate 
mirrors the growing concerns around autonomous vehicles. Criminal 
liability, the tort of negligence, and breach of warranty must be 
discussed before utilizing AI in medicine.58  Recently, the FDA 
                                                          
explainable-artificial-intelligence (last visited Dec. 3, 2018) (explaining that the 
“effectiveness of these [AI] systems is limited by the machine’s current inability to 
explain their decisions and actions to human users.”). 
55.  Clint Boulton, The Hidden Risk of Blind Trust in AI’s ‘Black Box’, CIO 
(July 6, 2017, 3:00 AM), https://www.cio.com/article/3204114/artificial-intelligence/ 
the-hidden-risk-of-blind-trust-in-ai-s-black-box.html.  
56.  See Andrew L. Beam & Isaac S. Kohane, Big Data and Machine Learning 
in Health Care, 319 JAMA 1317, 1317–18 (2018) (explaining the positive impact big 
data and machine learning has on the health care field). 
57.  See e.g., Keith J. Dreyer & J. Raymond Geis, When Machines Think: 
Radiology’s Next Frontier, 285 RADIOLOGY 713, 713, 715 (2017) (explaining 
mammograms, radiographs, and computed tomography as examples of areas suited 
for computer-aided diagnosis). 
58.  See J.K.C Kingston, Artificial Intelligence and Legal Liability, 2016 INT’L 
CONF. ON INNOVATIVE TECH. AND APPLICATIONS OF ARTIFICIAL INTELLIGENCE in 
RESEARCH AND DEVELOPMENT IN INTELLIGENT SYSTEMS XXXIII: INCORPORATING 
APPLICATIONS AND INNOVATIONS IN INTELLIGENT SYSTEMS XXIV 269, 269 (Bramer 
et al. eds., 2016) (using the example of self-driving cars to discuss “whether criminal 
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approved the first AI medical device for detecting diabetic retinopathy 
with an accuracy of 87% to 90%.59  Therefore, one solution to the 
concern of liability is if the automated product explains the limitations 
of the AI system, it might not be found liable.  When applying this 
framework, it should be clarified whether the programmer made a 
correct algorithm, the program was used properly, or if the quality and 
accuracy of the data were appropriate.  On the doctor’s side, the 
diagnosis and treatment should be determined by various aspects, 
including history-taking, physical examination, laboratory tests, and 
imaging.  Therefore, the majority of the responsibility will fall on 
doctors until the whole diagnostic AI system is established. 
Another concern with the implementation of AI in medicine is 
security.  Security issues are not limited to AI systems, other areas of 
AI will give rise to security concerns.  Therefore, new solutions and 
protections will continue to be required to ensure security.  In the future, 
when automation of diagnosis and surgery is established, security flaws 
will have the potential to cause serious human bodily harm. 
One concern is that AI decision-making, especially deep learning, 
often has no transparency.  This means that doctors and patients are not 
able to know how the AI system reached the decision.  The European 
Union’s General Data Protection Regulation (“GDPR”) is a regulation 
addressing data protection and privacy and recently went into 
enforcement May 25, 2018.60  Under the GDPR, people have the right 
to obtain “meaningful information about the logic involved” in 
automated decisions.61  This regulation will be difficult to comply with 
using deep learning.  Although developers must comply with the 
GDPR, this restrictive regulation may prevent further expansion of AI.  
A separate regulation or exception under the GDPR, which recognizes 
                                                          
liability could ever apply” to AI programs, and whether product liability or negligence 
should govern civil law with regards to AI programs).  
59.  See FDA Diabetes Detection Device, supra note 41 (finding an “[AI 
medical device] was able to correctly identify the presence of more than mild diabetic 
retinopathy 87.4% of the time and was able to correctly identify those patients who 
did not have more than mild diabetic retinopathy 89.5% of the time.”). 
60. GDPR Portal: Site Overview, EUGDPR, https://www.eugdpr.org/ (last 
visited Dec. 3, 2018). 
61.  Andrew D. Selbst & Julia Powles, Meaningful Information and the Right to 
Explanation, 7 INT’L DATA PRIVACY L. 233, 234 (2017). 
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the nuances of AI, data collection, and security would be preferable.62  
In addition, to being able to create a medical database for constructing 
AI systems, the database should be prioritized and supported by the 
government or large organizations.63  This is because data collected for 
AI systems is not just a registry of data from medical associations, it 
includes many types of integrated and sensitive data. 
D. Morality in the Future 
When analyzing the moral implications of AI, it is first important 
to discuss the patient benefits of direct-control robotic surgery using 
state-of-art technology.  The advantages of robotic surgery include 
“greater surgical precision, increased range of motion, improved 
dexterity, enhanced visualization, and improved access.”64  However, a 
recent large-scale study demonstrated that robotic surgery is associated 
with a prolonged operating time, doubling surgeries by over 4 hours, 
and higher hospital costs, about a 20% increase, compared with 
laparoscopic surgery.65  Maintenance costs are also high.66  In addition, 
in a robotic prostatectomy surgery, for the treatment of prostate cancer, 
                                                          
62.  C.f.  NAT’L SCI. AND TECH. COUNCIL COMM. ON TECH., EXEC. OFFICE OF 
THE PRESIDENT, Preparing for the future of artificial intelligence: AI and Regulation 
at 17 (2016) (“The general consensus of the RFI commenters was that broad 
regulation of AI research or practice would be inadvisable at this time. Instead, 
commenters . . . called for existing regulation to be adapted as necessary to account 
for the effects of AI.”). 
63.  See id. at 40–41 (recommending federal agencies “prioritize open training 
data and open data standards in AI” and that the government “prioritize basic and 
longterm AI research.”).  
64.  Da Vinci Surgery: Frequently Asked Questions, DA VINCI SURGERY, 
http://www.davincisurgery.com/da-vinci-gynecology/da-vinci-surgery/frequently-
asked-questions.php (last visited Dec. 3, 2018).  
65.  Laparoscopic surgery is an abdominal surgery using a long instrument 
through small incisions with a tiny video camera called a laparoscope. See In Gab 
Jeong, et. al., Association of Robotic-Assisted vs Laparoscopic Radical Nephrectomy 
with Perioperative Outcomes and Health Care Costs, 2003 to 2015, 318 JAMA 1561, 
1561–62 (2017) (discussing robotic-assisted surgery in patients receiving a radical 
nephrectomy). 
66.  See Chelsea Hill et al., Robotic Joint Replacement Surgery: Does 
Technology Improve Outcomes?, 34 THE HEALTH CARE MANAGER 128, 128 (2015) 
(discussing how the high costs of maintenance and upkeep for robotic equipment may 
hinder the use of robotics in hospitals). 
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there was no improvement in the primary outcome–survival rate and 
quality of life–or major complications.67  However, there were lower 
levels of blood loss and improvements in the functional recovery.68  
However even with robotic assistance, human error still exists.69  Even 
in direct controlled robotic surgery, the incidence of robotic 
malfunctions is still reported to be 3.7% during surgery.70  Although 
several challenges remain in direct-control robotic surgery, surgical 
errors made by autonomous robotic surgical devices will likely be one 
of the biggest legal issues in the future.  The surgical errors made by 
autonomous robotic surgical devices may have been avoided by a 
human doctor, but these devices may outgrow the need for humans in 
the future.  This raises these questions: should we continue developing 
these devices until the surgical error rate caused by the robot becomes 
zero and continue to allow patient injury caused by human error until 
we perfect the system?  Or should we recommend autonomous robotic 
surgery once satisfactory results are obtained at the sacrifice of a few 
patients?  Additional education is needed in the field of AI technology 
to answer these questions.  Also, there need to be meaningful 
discussions of the advantages, disadvantages, and ethics of autonomous 
robotic surgery. 
                                                          
67.  See Dragan Ilic et al., Laparoscopic and Robotic-Assisted versus Open 
Radical Prostatectomy for the Treatment of Localised Prostate Cancer, COCHRANE 
DATABASE OF SYSTEMATIC REVIEWS, Sept. 2017; see also Hyunsuk Frank Roh et al., 
Robot-Assisted Laparoscopic Surgery Versus Conventional Laparoscopic Surgery in 
Randomized Controlled Trials: A Systematic Review and Meta-Analysis, PLOS ONE, 
Jan. 23, 2018, at 1 (finding that “treatment outcomes between robotassisted 
laparoscopic surgery (RLS) and conventional laparoscopic surgery (CLS)” did not 
result in a “statistically better. . . . . outcome[], with the exception of lower estimated 
blood loss.”).  
68.  Roh et al., supra note 67, at 1 (noting the improvement in blood loss using 
robot-assisted laparoscopic surgery); see also Ilic et al., supra note 67 (finding that 
robot-assisted laparoscopic radical prostatectomy was better at preserving erectile 
function than a human only surgery). 
69. See Homa Alemzadeh et al., Adverse Events in Robotic Surgery: A 
Retrospective Study of 14 Years of FDA Data, PLOS ONE, Apr. 20, 2016, at 1, 3, 10 
(discussing various device malfunctions and errors that can occur when using robotic 
assistance in medical surgeries and procedures).  
70.  See Emad Rajih et al., Error Reporting from the Da Vinci Surgical System 
in Robotic Surgery: A Canadian Multispecialty Experience at a Single Academic 
Centre, 11 CANADIAN UROLOGICAL ASS’N J. 197, 199 (discussing an error rate of 
3.7% within the third generation of the da Vinci surgical system).  
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In the case of future treatments, an AI system may indicate that 
eligibility for an operation or treatment is met.  However, in practice, a 
doctor, considering the patient’s background or behavior, might 
consider that eligibility is not met empirically.  Which one, doctor or 
AI system, should have legal and moral authority regarding treatment 
in the face of inconclusive evidence?  Given the current state of 
technology, it should be the doctor.  However, if the doctor explains 
both treatment options, including the one by the AI system, while 
obtaining informed consent from the patient, the patient might be 
confused by the different treatment strategies.  The transparency of 
explanations provided by an AI system might affect the ethical 
relationship between doctor and patient.  In these instances, adequate 
information and education about AI decisions should be provided to the 
patient before a decision is required. 
V. THE ESSENTIALS OF MEDICAL ETHICS 
The American Medical Association provides several principles that 
define the essentials of honorable behavior of physicians.  The Code of 
Medical Ethics provides: 
I. A physician shall be dedicated to providing competent 
medical care, with compassion and respect for human 
dignity and rights. 
II. A physician shall uphold the standards of professionalism, 
be honest in all professional interactions, and strive to report 
physicians deficient in character or competence, or engaging 
in fraud or deception, to appropriate entities. 
III. A physician shall respect the law and also recognize a 
responsibility to seek changes in those requirements which 
are contrary to the best interests of the patient. 
IV. A physician shall respect the rights of patients, colleagues, 
and other health professionals, and shall safeguard patient 
confidences and privacy within the constraints of the law. 
V. A physician shall continue to study, apply, and advance 
scientific knowledge, maintain a commitment to medical 
education, make relevant information available to patients, 
colleagues, and the public, obtain consultation, and use the 
talents of other health professionals when indicated. 
VI. A physician shall, in the provision of appropriate patient 
care, except in emergencies, be free to choose whom to 
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serve, with whom to associate, and the environment in which 
to provide medical care. 
VII. A physician shall recognize a responsibility to participate in 
activities contributing to the improvement of the community 
and the betterment of public health. 
VIII. A physician shall, while caring for a patient, regard 
responsibility to the patient as paramount. 
IX. A physician shall support access to medical care for all 
people.71 
In principle, the italicized words could be replaced or complemented by 
AI.  To preserve their professionalism, physicians should use AI to 
respond to big data and make fewer misdiagnoses.  Also, to keep up 
with advancing scientific knowledge, doctors should learn to leverage 
AI technology.  The roles exemplified by the underlined words in the 
above code of ethics, however, i.e., those tasks specifically reflecting 
the humanity and legality of medicine, should not be performed by AI 
technology in its present state-of-art.  In the current state of technology, 
human doctors should maintain these roles. 
VI. CONCLUSION 
AI has a long history with various applications in medicine.  
However, recent advancements in deep learning will greatly affect 
diagnostic methods and treatments based on AI systems.  The 
algorithms of AI improve every year and will adapt to developments in 
areas like image diagnosis and robotic surgery in the future.  However, 
there are many issues that must be addressed before completing 
integrating AI in medicine.  Careful consideration must be given to 
possible situations and issues that may arise due to the rapid growth of 
technology.  A call to action is needed for further discussion about the 
applications of AI technology and policy proposals by legal 
professionals, physicians, ethics experts, and computer engineers to 
elucidate the limitations and potential problems of AI in medicine. 
 
                                                          
71.  American Medical Association, AMA Code of Medical Ethics, AMA 
(2001), https://www.ama-assn.org/sites/default/files/media-browser/principles-of-
medical-ethics.pdf (emphasis added).  
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